Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

BACKGROUND AND AIM: Thrombocytopenia is common in people with chronic liver disease, who frequently undergo invasive procedures. To minimize the risk of bleeding, prophylactic platelet transfusions have traditionally been used but carry many risks. The aim of this study was to evaluate the cost-effe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mladsi, Deirdre, Barnett, Christine, Aggarwal, Kavita, Vredenburg, Michael, Dieterich, Douglas, Kim, Ray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500829/
https://www.ncbi.nlm.nih.gov/pubmed/32982341
http://dx.doi.org/10.2147/CEOR.S262772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500829/
https://www.ncbi.nlm.nih.gov/pubmed/32982341
http://dx.doi.org/10.2147/CEOR.S262772

Ejemplares similares